January 17, 2024
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this notice is to inform applicants of an extension to PAR-21-122, Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed), PAR-21-123 Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed), PAR-21-124 Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) by one additional council round. The following application due dates have been added to these notices of funding opportunity (NOFOs): New Application Due Date: October 21, 2024, Resubmission/Revision Due Dates: October 21, 2024, Expiration Due Date: October 22, 2024. Changes to the NOFOs are shown below:
Currently Reads:
Application Due Dates | Review and Award Cycles | ||||
New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
June 17, 2021 | June 17, 2021 | Not Applicable | October 2021 | January 2022 | February 2022 |
October 19, 2021 | October 19, 2021 | Not Applicable | February 2022 | May 2022 | June 2022 |
February 22, 2022 | February 22, 2022 | Not Applicable | June 2022 | October 2022 | November 2022 |
June 21, 2022 | June 21, 2022 | Not Applicable | October 2022 | January 2023 | February 2023 |
October 18, 2022 | October 18, 2022 | Not Applicable | February 2023 | May 2023 | June 2023 |
February 21, 2023 | February 21, 2023 | Not Applicable | June 2023 | October 2023 | November 2023 |
June 20, 2023 | June 20, 2023 | Not Applicable | October 2023 | January 2024 | February 2024 |
October 20, 2023 | October 20, 2023 | Not Applicable | February 2024 | May 2024 | June 2024 |
February 20, 2024 | February 20, 2024 | Not Applicable | June 2024 | October 2024 | November 2024 |
June 20, 2024 | June 20, 2024 | Not Applicable | October 2024 | January 2025 | February 2025 |
Expiration Date: June 21, 2024
Modified to Read:
Application Due Dates | Review and Award Cycles | ||||
New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
June 17, 2021 | June 17, 2021 | Not Applicable | October 2021 | January 2022 | February 2022 |
October 19, 2021 | October 19, 2021 | Not Applicable | February 2022 | May 2022 | June 2022 |
February 22, 2022 | February 22, 2022 | Not Applicable | June 2022 | October 2022 | November 2022 |
June 21, 2022 | June 21, 2022 | Not Applicable | October 2022 | January 2023 | February 2023 |
October 18, 2022 | October 18, 2022 | Not Applicable | February 2023 | May 2023 | June 2023 |
February 21, 2023 | February 21, 2023 | Not Applicable | June 2023 | October 2023 | November 2023 |
June 20, 2023 | June 20, 2023 | Not Applicable | October 2023 | January 2024 | February 2024 |
October 20, 2023 | October 20, 2023 | Not Applicable | February 2024 | May 2024 | June 2024 |
February 20, 2024 | February 20, 2024 | Not Applicable | June 2024 | October 2024 | November 2024 |
June 20, 2024 | June 20, 2024 | Not Applicable | October 2024 | January 2025 | February 2025 |
October 21, 2024 | October 21, 2024 | Not Applicable | February 2025 | May 2025 | June 2025 |
Expiration Date: October 22, 2024
All other aspects of these NOFOs remain unchanged.
Becky Roof, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: [email protected]